Merck & Company, Inc. Price Today
Merck & Company, Inc.
MRK
Healthcare
$266.43B
💰
Market Cap
20.5
💸
Price to Earnings
$5.1
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
15 |
Strong Buy |
9 |
Hold |
9 |
Sell |
0 |
Strong Sell |
0 |
MRK Price Forecast Target
105.0 👉 122.4 +17%
MRK EPS Forecast
5.1 👉 7.7 +50%
Financials
Profit Margin
5 %
Revenue Growth
3.0 %
Dividend
$ 2.92
Held Percent
0.1% - Insiders
77.6% - Institutions
22.3% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $26.0B
-
💰 Blackrock Inc. $22.2B
-
💰 State Street Corporation $12.4B
-
💰 Wellington Management Group, LLP $7.3B
-
💰 Geode Capital Management, LLC $5.4B
Stock Ideas
Michael Platt Portfolio
Michael Platt is the founder and CEO of BlueCrest Capital Management, a global macro hedge fund with a focus on systematic trading strategies. Prior to starting BlueCrest, Platt worked as a portfolio manager and trader, gaining experience across glo…
Jim Simons Portfolio
Jim Simons, the mastermind behind the Medallion Fund, has achieved such extraordinary returns that he has skyrocketed to the ranks of the world's wealthiest individuals. The secret to his success lies in the fund's implementation of high-frequency t…
Stephen Mandel Portfolio
Stephen Mandel is the founder and portfolio manager of Lone Pine Capital, one of the largest and most successful hedge funds. Employing rigorous fundamental analysis, Mandel searches globally for qualitatively excellent growth companies trading at r…
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.📮FAQ
Some Frequently Asked Questions.
The Merck & Company, Inc. industry is Drug Manufacturers—General
The Merck & Company, Inc. sector is Healthcare
The Merck & Company, Inc. forecasted predicted Price to Earnings PE ratio is 13.7
The Merck & Company, Inc. Price to Earnings PE ratio is 20.5
The Market Capitalization of Merck & Company, Inc. is $266.43B
There are total of 2534441780 float shares with 77.6% held by Institutions and 0.1% held by insiders
The MMerck & Company, Inc. forecasted Earnings per Share EPS is $7.7
The Merck & Company, Inc. Earnings per Share EPS is 5.1
The Merck & Company, Inc. company has $42077000000 gross profits with 5 profit margins
The Merck & Company, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Merck & Company, Inc. Revenue is $58311000064 with 0.03 revenue growth
The price target for Merck & Company, Inc. stock is $122.4 for the high target and $99.8 for the low target
The consensus analyst recommendations for Merck & Company, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Merck & Company, Inc. is Buy, with the following breakdown:
- Buy: 15
- Strong Buy: 9
- Hold: 9
- Sell: 0
- Strong Sell: 0
The Beta of Merck & Company, Inc. is 0.3
The dividend of Merck & Company, Inc. is $2.92
The dividend yield of Merck & Company, Inc. is 0.0278%
The biggest institutional and mutual fund holders of Merck & Company, Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
- Wellington Management Group, LLP
The Merck & Company, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0